arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Picard Medical, Inc.

PMI

$4.51 ▲ +0.27 (+6.37%) at close

11 Visible periods

28 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Picard Medical, Inc. faces fundamental challenges. The fundamentals warrant careful consideration of downside risks.

Market Cap $8.4M

Dividend Yield —

Revenue Growth 38.6% ↘

Op. Margin -156.7% ↗

ROIC -270.1% ↘

FCF / Share $-0.73 ↘

Trailing P/E —

Price / Book 5.4x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Sep 23, 2026.

11-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$2.95M

↑ +38.6% —

Net Income Profit after all expenses

$-7.62M

↓ -13.3% —

Operating Margin Operating profit as % of sales

-156.7%

↑ +60.1% 0th

FCF / Share Free cash flow per share

$-0.73

↓ -1317.4% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile

Health Breakdown

Profitability →

Financial Health ↑

Cash Quality →

Dividend History

Dividend / share · sourced from SEC filings

$0.00 Latest / share

Q4 FY2023

Q1 FY2024

Q2 FY2024

Q3 FY2024

Q4 FY2024

Q1 FY2025

Q2 FY2025

$0.00

Q3 FY2025

Q4 FY2025

Q1 FY2026

Q2 FY2026

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Revenue Growth YoY (%)	38.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+383%)	85.5% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+969%)	20.7% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+159%)	34.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+334%)	207.1% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2488%)	—	—	—	—	—	—
EPS Growth YoY (%)	—	87.5% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	N/M	78.2% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-13.3% Weak ↑ Weak Improving Year-over-year change in net income	-37.0% Weak ↑ Weak Improving Year-over-year change in net income	51.4% Excellent ↑ Excellent Improving Year-over-year change in net income	-184.6% Weak Weak Year-over-year change in net income	-65.7% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	—	81.7% Excellent Excellent Year-over-year change in free cash flow	—	63.6% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Operating Margin (%) (%)	-156.7% Weak ↑ Weak Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1145%)	-392.3% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2715%)	-297.6% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2084%)	-293.8% Weak → Weak Stable Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2058%)	-165.2% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1202%)	—	-427.3% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2948%)	—	—	—	—
Effective Tax Rate (%) (%)	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	-0.6% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.2% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
Profit Margin (%) (%)	-257.8% Weak ↑ Weak Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2248%)	—	-425.3% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3644%)	-468.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-4004%)	-315.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2729%)	—	—	-221.8% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1948%)	—	—	—
FCF Margin (%) (%)	-45.8% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-332.7% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-433.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-361.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-377.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-296.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—
FCF / Net Income (x)	0.18x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	1.02x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	1.17x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.40x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.33x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Return on Invested Capital (%)	-270.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	311.5% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-79.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-43.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.1% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	6.7% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	8.1% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	12.6% Good Good Return earned on debt + equity capital invested Optimal: > 10%	10.2% Good Good Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-50.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-40.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-13.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-25.8% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-30.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-29.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	—	—	-113.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-855%)	-69.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-565%)	12.3% Fair → Fair Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-18%)	11.4% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-24%)	20.1% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	5.5% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-63%)	13.7% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-9%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Interest Coverage (x)	-58.59x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-751.83x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-600.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-13.73x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-1.45x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-3572.00x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-4444.00x Weak Weak Operating income divided by interest expense Optimal: > 5x	-22.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-38.00K	$-121.00K	$-7.45M	$-2.81M	$-410.00K	—	$-96.00K	—	—	—	—

📊 What does each share earn? 8 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Revenue per Share (USD)	$1.59	$0.02	—	$0.02	—	$0.08	—	$0.11	—	—	—
Basic EPS, GAAP (USD)	$-3.05	$-0.10	$0.21	$-0.19	—	$-0.80	$-1.20	$-0.87	—	—	—
Free Cash Flow per Share (USD)	$-0.73	$-0.05	—	$-0.12	—	$-0.28	—	$-0.33	—	—	—
Dividend per Share (USD)	—	—	—	$0.00	—	—	—	—	—	—	—
Book Value per Share (USD)	$0.83	$-0.02	$0.05	$0.11	$-5.87	$-6.14	$-5.54	$-4.46	—	—	—
Tangible Book Value per Share (USD)	$0.31	$-0.03	$0.04	$0.09	$-5.99	$-6.14	$-5.69	$-4.46	—	—	—
Basic Weighted Avg Shares (shares)	1.86M	74.44M	—	54.45M	—	7.96M	—	7.94M	—	—	—
Dividend Payout Ratio (%)	—	—	—	0.0% Excellent Excellent Dividends paid as a percentage of earnings Optimal: 30-60%	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Working Capital (USD)	$141.00K	$-3.15M	$2.03M	$6.21M	$-35.99M	—	$-25.53M	—	—	—	—
Total Equity (USD)	$1.72M	$-1.45M	$3.79M	$7.97M	$-54.49M	$-48.92M	$-44.00M	$-35.40M	$-29.64M	$-25.77M	$-23.82M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗
Sales/Revenue/Turnover (USD)	$2.95M	$1.15M	$1.01M	$1.19M	$2.13M	$620.00K	$836.00K	$881.00K	$694.00K	—	—
Depreciation Expense (USD)	$45.00K	$46.00K	$40.00K	$41.00K	—	$42.00K	$42.00K	$21.00K	—	—	—
Net Income, GAAP (USD)	$-7.62M	$-7.62M	$-4.29M	$-5.56M	$-6.72M	$-5.56M	$-8.84M	$-1.95M	$-4.06M	—	—
Operating Cash Flow (USD)	$-1.35M	$-3.80M	$-4.38M	$-6.51M	—	$-2.24M	$-3.15M	$-2.61M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 3 years · 11 quarters

Picard Medical, Inc.

Analytical Summary

11-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Dividend History

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare PMI with peers